Psychiatric disorders associated with fluoroquinolones: a pharmacovigilance analysis of the FDA adverse event reporting system database

Overview of attention for article published in Frontiers in Pharmacology, October 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (58th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 4 X users

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 7,632 followers.

RT @FrontPharmacol: New Research: Psychiatric disorders associated with fluoroquinolones: a pharmacovigilance analysis of the FDA adverse e…

14 Oct 2024

Reply Repost Favourite

RT @FrontPharmacol: New Research: Psychiatric disorders associated with fluoroquinolones: a pharmacovigilance analysis of the FDA adverse e…

14 Oct 2024

Reply Repost Favourite

RT @FrontPharmacol: New Research: Psychiatric disorders associated with fluoroquinolones: a pharmacovigilance analysis of the FDA adverse e…

14 Oct 2024

Reply Repost Favourite

New Research: Psychiatric disorders associated with fluoroquinolones: a pharmacovigilance analysis of the FDA adverse event reporting system database https://t.co/z8HpdAWoqG #FrontiersIn #Pharmacology

14 Oct 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.